Quick Answer
Whitehawk Therapeutics, Inc. reported Common Stock Shares Outstanding of 47.15 million shares for the year ending 2025.
- Whitehawk Therapeutics, Inc. showed an increase of +91.0% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Whitehawk Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2010 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2010 to 2025), Whitehawk Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 842.9%.
- Historical annual values: Fiscal year 2025: 47.15 million shares | Fiscal year 2024: 24.68 million shares | Fiscal year 2023: 24.55 million shares | Fiscal year 2022: 24.44 million shares | Fiscal year 2021: 20.89 million shares | Fiscal year 2021: 2.50 million shares | Fiscal year 2020: 2.54 million shares | Fiscal year 2019: 40.59 million shares | Fiscal year 2018: 40.59 million shares | Fiscal year 2017: 27.07 million shares | Fiscal year 2016: 1.24 million shares | Fiscal year 2015: 5.00 million shares | Fiscal year 2014: 5.00 million shares | Fiscal year 2013: 5.00 million shares | Fiscal year 2012: 5.00 million shares | Fiscal year 2011: 5.00 million shares | Fiscal year 2010: 5.00 million shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: